Reference : Impact of Serial B-Type Natriuretic Peptide Changes for Predicting Outcome in Asympto...
Scientific journals : Article
Human health sciences : Cardiovascular & respiratory systems
http://hdl.handle.net/2268/190028
Impact of Serial B-Type Natriuretic Peptide Changes for Predicting Outcome in Asymptomatic Patients With Aortic Stenosis.
English
Henri, Christine [> >]
DULGHERU, Raluca Elena [Centre Hospitalier Universitaire de Liège - CHU > > Cardiologie >]
Magne, Julien [> >]
Caballero, Luis [> >]
Laaraibi, Saloua [> >]
DAVIN, Laurent mailto [Centre Hospitalier Universitaire de Liège - CHU > > Cardiologie >]
Kou, Seisyou [> >]
Voilliot, Damien [> >]
Nchimi, Alain [> >]
Oury, Cécile mailto [Université de Liège > Département des sciences biomédicales et précliniques > GIGA-R : Génétique humaine >]
Pierard, Luc mailto [Université de Liège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation >]
LANCELLOTTI, Patrizio mailto [Centre Hospitalier Universitaire de Liège - CHU > > Cardiologie >]
2016
Canadian Journal of Cardiology
Yes (verified by ORBi)
International
0828-282X
1916-7075
[en] BACKGROUND: The aim of this study was to determine the impact on the outcome of serial B-type natriuretic peptide (BNP) changes during follow-up in asymptomatic patients with >/= moderate aortic stenosis (AS) and preserved left ventricular ejection fraction. METHODS: We prospectively screened 69 patients who underwent comprehensive transthoracic echocardiography, BNP level measurement at baseline and after every 6 or 12 months. Annualized BNP changes were calculated as the difference between the last and baseline BNP measurements divided by the duration of follow-up. The primary endpoint was the occurrence of symptoms, aortic valve replacement, or cardiovascular death. RESULTS: During a follow-up of 30 +/- 19 months, 43 patients experienced a cardiac event. These patients were significantly older (73 +/- 9 vs 65 +/- 16 years; P = 0.010), had more often dyslipidemia (79% vs 42%; P = 0.038), more severe AS (peak velocity: 3.9 +/- 0.6 vs 3.5 +/- 0.6 m/s; P = 0.002), larger indexed left atrial area (10.2 +/- 2.5 vs 8.7 +/- 1.9 cm2/m2; P = 0.006), and a higher increase in annualized BNP (+90 +/- 155 vs +7 +/- 49 pg/mL/y; P = 0.010). Patients with higher annualized BNP changes (> 20 pg/mL/y) had a significantly lower cardiac event-free survival (1 year: 63 +/- 8% vs 97 +/- 3%; 3 years: 31 +/- 8% vs 68 +/- 8%; P < 0.001). Using the multivariate Cox proportional hazards model, higher annualized BNP changes were significantly associated with increased risk of cardiac events (hazard ratio: 2.73, 95% confidence interval: 1.27-5.86; P = 0.010) after adjustment for age, dyslipidemia, and echocardiographic parameters. CONCLUSIONS: In asymptomatic patients with AS and preserved left ventricular ejection fraction, the use of serial BNP changes may help to anticipate development of class I indication for aortic valve replacement.
http://hdl.handle.net/2268/190028
10.1016/j.cjca.2015.06.007
Copyright (c) 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
impact of serial b.pdfPublisher postprint732.05 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.